While Neogenomics Inc has underperformed by -0.55%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, NEO fell by -18.04%, with highs and lows ranging from $21.22 to $12.77, whereas the simple moving average jumped by 8.79% in the last 200 days.
On December 10, 2024, Jefferies started tracking Neogenomics Inc (NASDAQ: NEO) recommending Buy. BTIG Research also reiterated NEO shares as ‘Buy’, quoting a target price of $21 on the company’s shares in a report dated December 29, 2023. Raymond James May 16, 2023d its ‘Outperform’ rating to ‘Mkt Perform’ for NEO, as published in its report on May 16, 2023. BTIG Research’s report from May 09, 2023 suggests a price prediction of $25 for NEO shares, giving the stock a ‘Buy’ rating. The Benchmark Company also rated the stock as ‘Buy’.
Analysis of Neogenomics Inc (NEO)
Further, the quarter-over-quarter increase in sales is 10.44%, showing a positive trend in the upcoming months.
Neogenomics Inc’s future performance can be determined with the help of several well-rounded types of analysis and research techniques, with equity being one of the most influential. The goal here is to ensure that your current return on equity of -8.38% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 1.91, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
The average volume for any stock is also a very valuable indicator of volatility, and NEO has an average volume of 762.75K. On a monthly basis, the volatility of the stock is set at 4.00%, whereas on a weekly basis, it is put at 4.83%, with a loss of -8.38% over the past seven days. Furthermore, long-term investors anticipate a median target price of $20.69, showing growth from the present price of $16.40, which can serve as yet another indication of whether NEO is worth investing in or should be passed over.
How Do You Analyze Neogenomics Inc Shares?
In addition to analyzing the fundamentals, it is also important to look at how many company employees own stock. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.19%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 97.50% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
NEO shares are owned by institutional investors to the tune of 97.50% at present.
